Research Paper | Finance | India | Volume 9 Issue 8, August 2020
A Study on Financial Performance of Pharmaceutical Company
Sejal S. Purabiya
India is the bigger producer of generic drugs globally. Indian pharmaceutical sector industry supplies over 50 per cent of world demand for different types vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicine in UK. India enjoys higher position in the global pharmaceuticals sector. The country also has a large bulk of scientists and engineers who have the potential to steer the industry onwards to an even higher level. In Present over 80 per cent of the antiretroviral drugs used globally to combat AIDS (Acquired Immune Deficiency Syndrome) are supplied by Indian pharmaceutical firms. In India almost 250 bigger units and around 8000 small scale units, which method the fundamental of the pharmaceutical manufacturing in India. (calculating 5 central public sector units) discerning fast, the world wide pharma market stands inert valued to extra than dual to $ 1.3 billion by the year 2020.Thus, a sweat has been around to study the effectiveness place of the industry with the profit of harsh, standard deviation, co-efficient of variance, multiple regression and study of varies. The growth in profitability will not only yield higher effectiveness then also advance financial performance in future.
Keywords: Finacial ratio, leverage, profitability ration
Edition: Volume 9 Issue 8, August 2020
Pages: 101 - 103
How to Cite this Article?
Sejal S. Purabiya, "A Study on Financial Performance of Pharmaceutical Company", International Journal of Science and Research (IJSR), https://www.ijsr.net/search_index_results_paperid.php?id=SR20729151615, Volume 9 Issue 8, August 2020, 101 - 103